Jonathan M Kurie

101PUBLICATIONS
668CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersGenomics and transcriptomicsElectrical energy generation (incl. renewables, excl. photovoltaics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (101)

|Sep 14, 2026
P-Loop/αC-Helix Compressing Mutations and Exon 20 Insertions in EGFR-Mutant NSCLC: A Rapidly Evolving Therapeutic Landscape.

|Aug 28, 2026
Perioperative Durvalumab for Resectable Non-Small Cell Lung Cancer: Updated Outcomes From the Phase III AEGEAN Trial.

|Jul 27, 2026
The genomic landscape and treatment outcomes associated with CDKN2A/MTAP loss in patients with non-small cell lung cancer.

|Jun 13, 2026
Deciphering small sequence differences in T cell receptor-antigen pairing.

|May 18, 2026
Clinical Outcomes and Predictors of Response to PD-(L)1 Blockade in Patients with NSCLC without Actionable Genomic Alterations Who Never Used Tobacco.

|May 13, 2026
BLU-451, a CNS-Active, Potent, and Selective Small-Molecule Inhibitor Against Uncommon EGFR Mutations.

Pageof 17

Frequent Collaborators

40 joint publications

Jianjun Zhang

37 joint publications

Don L Gibbons

26 joint publications

Jack Lee

25 joint publications

Xiuning Le